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Abstract:

Muscle atrophy and decreased strength are an accepted part of
ag1ng.

While physical inactivity may account for some of these

losses, physically active individuals still exper1ence age related
reduction in muscle mass and strength.

The purpose of this study

is to examine the effects that aging has on skeletal muscle
regeneration.

It is hypothesized that the recovery of muscle mass

and force following muscular injury will decrease with age.
anesthetic bupivacaine, a potent myotoxic agent,

The

was injected

into the left tibial is anterior (TA) of young, adult, and
senescent rats (3, 18, 31 months).
internal control.

The right leg served as an

Following a 2, 3, or 4 week recovery period,

the mass and isometric force of each TA were measured.

In the

young animals, the mass of the bupivacaine injected leg was 60% of
the control value at two weeks post injection.
the mass was fully recovered.
animals,

By three weeks,

In the middle age and senescent

mass of the injected TA was approximately 50% of the

control at two weeks and remained at 50% of control following 3
and 4 weeks recovery.
parallel trends.

Muscle force measurements demonstrated

These results indicate that skeletal muscle

regeneration is impaired in middle age and senescent rats.
Recently,

a

family of four genes was identified that causes

the express1on of skeletal muscle specific proteins when activated

1n precursor cells.

One member of this family is myogen1n.

It 1s

known that myogenin is expressed only during skeletal muscle
regeneration, making it an excellent marker for this process.
Myogenin mRNA levels were measured in the control and experimental
TA muscles of the young , middle age, and senescent animals used
in this experiment.

All three age groups have elevated levels of

myogen1n mRNA in the bupivacaine-injected TA when compared to the
control.

In addition,

the 31 month animals have significantly

higher levels of myogenin mRNA in their control legs at all time
periods than those found in the other age groups .

It is known

that the expression of myogenin is down-regulated by electrical
activity.

The high

levels found in the control leg indicate

reinnervation problems during regeneration in the old animals .

Introduction:

Webster's Compact Dictionary defines disease as, "a
condition of the body that impairs its normal functioning . "
Skeletal muscle atrophy is prevalent among the elderly and is a
leading cause of impaired mobility in the aging members of our
population. (Fitarrone et al., 1994).

Such a loss of mobility

leads to dependence and greatly decreases the quality of life in
the later years.

In addition, it was estimated that$ 10 billion

are spent yearly to treat fall related fractures in the elderly
that occur as a direct result of insufficient muscle strength and
endurance (Tinetti et al., 1994).

While these decreases 1n

muscular strength and mobility are often attributed to a sedentary
lifestyle, trained athletes who show higher strength and power
than normal individuals, still experience similar declines in
structural and functional properties throughout their lifetime
(Brooks and Faulkner, 1994).

Despite the obvious impairment of

normal functions caused by muscle atrophy with aging, the medical
field has done little to investigate the causes behind this loss.
Quetelet (1835) originally correlated impaired skeletal
muscle function with age over 150 years ago.

Since that time,

a

significant amount of information has been gathered on the
subject.

Today it 1s known that human skeletal muscle begins to
1

atrophy at 25 years of age in men. Muscle mass decreases 10% over
the next 25 years without a corresponding loss in strength (Lexall
et. al. 1986).

After the age of 50, however, there is a 30% loss

of muscle mass by the age of 80.

Closely associated with this is

a 22% loss of muscle strength that occurs between the ages of 4550 and 60-65 years of age ( Larrson et al . , 1978).

Similar losses

of mass and strength occur a few years later in women.

While

other possibilities have been proposed, an increased
susceptibility to injury coupled with a decreased ability to
recover from injury may be a major cause of muscle atrophy and
weakness seen in old animals and the elderly .
Skeletal muscle is a dynamic tissue.

It 1s constantly

injured and repaired throughout the course of a normal day due to
the contractions that allow for movement.

Such damage 1s

generally focal in nature, with 20 - 30% of muscle fibers being
damaged during eccentric exerc1se.

When studying regeneration, it

is often advantageous to observe wide spread muscular damage.

As

a result, various methods including pinching, freezing, and
anesthetic injections have been used to induce the degeneration/
regeneration process in laboratory animals.

The ability of

skeletal muscle to regenerate following such injury is well
documented, although the extent and success of regeneration var1es
2

with the extent and cause of injury (Grounds, 1991).
Following extreme damage, muscles lose their ability to
contract, but regain some degree of function during regeneration.
Of particular interest, is the recovery of contractile properties
following

a

localized injection of the anesthetic bupivacaine.

Following grafting, pinching, or freezing, contractile properties
are only partially restored (Carlson et al., 1983).

After

a

bupivacaine injection, however, muscle mass and contractile
properties are completely restored within 3-4 weeks
(Rosenblatt, 1992). Only 15 minutes after the injection of
bupivacaine, the sarcolemma is disrupted, the sarcoplasmic
reticulum dilates, myofibrils hypercontract, and the myonuclei are
disrupted (Bradley, 1979).

Over the next 12 hours, the myofibrils

rupture, and the sarcolemma dissolves resulting in cytoplasm
fragmentation (Hall-Craggs 1974).

Macrophages begin to engulf

necrotic fibers at 12 hours post injury and infiltrate the tissue
by 24 hours (Nonaka et. al . , 1983).

Myoblasts are observed after

the first day and fuse to form mature myotubes within 4 weeks
(Rosenblatt, 1992).
The fast action and complete recovery are due to the
selective action of the drug on myofibrils and lack of damage to
the muscle's satellite cell population (Hall-Craggs, 1980b), basal
3

lamina (Hall-Craggs, 1980a), vascular supply (Grim et al., 1983)
and intramuscular nerves (Tomasi Ferre et al., 1989).

The other

methods selectively damage one or more of these 3 elements,
greatly limiting regenerative possibilities. Thus, bupivacaine
provides an excellent opportunity for studying skeletal muscle
regeneration in an ideal environment.
The regenerative process involves revascularization, invasion
of phagocytic cells, removal of damaged tissue, proliferation and
fusion of precursor cells, and reinnervation (Grounds, 1991).
Each of these steps 1s necessary.

Without their ordered

occurrence regeneration is not successfully completed.

The

following is a brief discussion of the events that occur during
regeneration.
Revascularization 1s extremely important to the regeneration
of skeletal muscle.

Upon removal of the vascular supply, the

majority of the myotubes, except for
degenerate.

a

few at the periphery,

The peripheral fibers are kept alive by the diffusion

of nutrients and gases from vessels in neighboring tissues
(Carlson, 1981).

In general, regeneration trails behind

revascularization because blood supplies the oxygen and nutrients
necessary for new tissue formation.

The mechanisms behind

revascularization are poorly understood.
4

It is known that the new

vascular tissue comes from small neighboring vessels rather than
major vessel.

a

This indicates that angiogenic factors released

from the area of injury may cause local blood vessels to branch
towards the damaged tissue.

Such factors have yet to be

identified.
Slightly before revascularization,

a

few macrophages enter

the damaged tissue and begin removing debris (Hansen-Smith et al.,
1979 and Roberts et al., 1990). Shortly following

revascularization, a wave of leukocytes enters the tissue and
phagocytizes the debris.

This process is important because

regeneration is inhibited by persisting necrotic tissue.

Removal

of dead tissue creates room for new myotubes to form.
The normal growth and repair of muscle fibers is carried out
by satellite cells.

These are undifferentiated muscle precursor

cells located between the sarcolenma and basal lamina of a muscle
fiber.

They cause normal growth and repair by either fusing with

existing fibers (hypertrophy) or forming new myotubes
(hyperplasia) (Schultz, 1990).

In addition, satellite cell

proliferation is responsible for the addition of new myonuclei 1n
regenerating muscles (Snow, 1977).

Satellite cells are normally

quiescent and are activated following injury.

The factors that

directly or indirectly control their proliferation and fusion are
5

unknown due to the complexity of the situation.

It is known,

however, that a decrease in either satellite cell number or
activity would decrease regenerative capabilities.
The establishment of a functional neuromuscular synapse 1s
critical for the maturation of regenerating muscle fibers.
Without neural activity, the regenerating tissue dies.

Motor

axons generally make contact with regenerating tissue in the same
area as the original endplate.

Although neighboring axons can

sprout and innervate the regenerating tissue, the same axon that
innervated the fibers before injury generally innervates the
regenerated fibers (Fowler, 1994).

It is also known that nerve

growth factor (NGF) acts as a chemotactic agent and is responsible
for the sprouting of axons.
An extremely important step during regeneration is
Myogenesis is characterized by the proliferation and

myogenes1s.

fusion of satellite cells.
cells are inactive.
activated.

Under normal conditions, satellite

Following injury, however, they are

Such activation occurs via a recently identified

family of genes. This family consists of myogenin (Edmonson and
Olson, 1989),

Myo 01 (Davis et al., 1987), myf 5 (Braun et al.,

1989), and herculin/MRF 4 (Miner and Wold, 1990).

All four genes

have homologous sequences, including an area which codes for a
6

ser1es of basic am1no acids that is responsible for the DNA
binding ability of the proteins (Davis et al., 1990).

Their

express1on ultimately leads to the expression of muscle specific
proteins.

Recent studies report that predominantly quiescent

satellite cells do not express any members of the myogenic family
(Grounds et al., 1992 and Fuchtbauer & Westphal, 1992).

In

addition, Grounds (1991) reported that the expression of myo 01
and myogenin was apparent six hours following crush injury to
skeletal muscle.

Thus, myogenin is only expressed in regenerating

skeletal muscle, making it an excellent marker for this process.
In light of this information, the purpose of this study is to
examine the effects of aging on skeletal muscle regeneration . More
specifically, the temporal relationship of muscle regeneration,
recovery of muscle force, and myogenin mRNA expression in young,
adult, and aged rat skeletal muscle are investigated.

The

following hypotheses are tested:
1)

Recovery of muscle mass and force generating capacity following

injury occurs later with age.
2) The expression of myogenin mRNA will differ 1n the regenerating
muscle of young, adult, and aged rats.

7

Results of this experiment indicate that skeletal muscle
regeneration is impaired with age, pointing to it as a probable
cause of age-related atrophy.

Methods:

Animals:

The rats used in this experiment were male Brown Norway-

Fischer 344 cross.

Fifteen 3 month, 18 month, and 33 month rats

were purchased from the NIH Aging program in Indianapolis.
arrival they were placed in temperature (21°C) and light

Upon

C 12:12

hr . light/dark) controlled quarters in the University of TexasHouston Medical Center animal care facility.
two per cage and

isolated from other animals.

was sterilized by autoclave.

The rats were housed
All food and water

Protocols were approved by the

Institutional Animal Welfare Committee.

Bupivacaine Injection:

The animals were anesthetized with an

intramuscular injection (0.84 ml/kg) of ketamine(54 mg/ml),
xylazine (2.2 mg/ml), and acepromazine (3.5 mg/ml).

An incision

was made over the distal third of the left tibial is anterior (TA).
A

25 gauge 5/8" needle (0.5x16 mm) needle was inserted along the

longitudinal axis of the muscle.

While the needle was slowly

withdrawn, 0.5 ml of 0.75% bupivacaine was injected into the
8

muscle.

A similar injection was administered at

a

15° angle, 3 nm

away from the original injection.

The right leg was undisturbed

and served as an internal control.

Once the animals recovered,

they were returned to their cages.

Force Measurements: Following two, three, or four weeks recovery
the rats were anestithized with an intramuscular injection of the
ketamine cocktail described earlier.

An incision was made through

the quadriceps femoris, exposing the deep peroneal nerve.
electrodes were sutured to the nerve.

Two

The nerve was severed to

prevent stimulation of the lower limb via the central nervous
system.

The rats were placed in a heated box.

Anesthetic causes

body temperature to drop. Any significant change in body
temperature would have affected force measurements.
was wired to the electrodes.
a

force transducer.

A stimulator

The tendon of the TA was attached to

Computer programs were used to determine

optimal muscle length and current for force measurement.

Force

measurements were taken at 50, 75, 100, 150, 200, 250, and 300 HZ.
Average force was calculated for each leg using the frequency that
caused tetany.

Muscle Sampling:

Inmediately following force measurements the

rats were anestithized and the TA was removed from each limb. They
9

were frozen with liquid nitrogen-cooled Wollenberger tongs.
Muscle samples were frozen at -80°( until further analysis.

Rats

were sacrificed by cervical dislocation while under anesthesia.

Total RNA Isolation and Quantification:

Tibial is anterior

muscles were individually powdered under liquid nitrogen using a
mortar and pestle.

Total RNA was extracted from 150-300 mg

samples of each muscle using the guanidine thiocyanate method of
Chomczynski and Sacchi (1987) with Trisolve (Biotecx
Laboratories).

The RNA was dissolved in diethylpyrocarbonate

treated water and quantified spectrophotometrically at 260 nm.
RNA integrity was confirmed by examining an ethidiumbromide
stained gel of 18S and 28S rRNA prior to its use in Northern
Blots.

Myogenin mRNA determination:

Northern blot analysis was

used to assess the concentration of myogenin in all muscles.
Separate 15 ug samples of RNA were loaded onto 1% agarose / 6.7%
formaldehyde gels and electrophoresed at 5 V/cm for 2.5 hours.
The RNA was transferred to nylon membranes via capillary action
and ultraviolet cross-linked to the membrane (Carson et.al.,1995).
10

Full length cDNA for rat myogenin provided by Dr. Victor K.
Lin was subcloned into the plasmid vector pBluescript (Wright et
al., 1989).

A cDNA insert was cut from the plasmid (EcoRI) and

random primed.

The RNA containing membrane was prehybridized

with 12 ml of hybridization buffer (Quick Hyb, Stratagene) for 30
minutes at 68°C.

An aliquot of random primed myogenin cONA probe

was mixed with the hybrization buffer and incubated for 2 hours at
68°C.

The membrane was then washed twice in Zx sodium chloride -

sodium citrate (SSC) - 0.1% sodium dodecylsulfate (SOS) for 15
minutes at 20°c.
30 minutes at

It was washed again with 0.1 SSC - 0.1 SOS for

ss 0 c.

The membrane was autoradigraphed (-80°C, 30

min.) and the band corresponding to myogenin mRNA was quantified
by densitrometric scanning (Bioimage) and normalized to ethidium
bromide stained 28s rRNA.

Statistical Analysis:

All statistical analysis was done us1ng a

standard statistical package on a Macintosh computer.
software used was Gopher.
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The

Results:

Muscle Mass and Force:

The mass of the individual control and

bupivacaine injected TA muscles are compared for each age group
(Fig. 1).

At two weeks post-injection, the mass of the injected

TA (3 mo. rats) was 77 % of control values.
105% of the control value.

weeks post-injection.

At three weeks it was

It remained at this level at four

In the 18 month animals, injected muscle

mass was 53%, 64%, and 64% of control values following 2,3, and 4
weeks recovery respectfully.

The results from the 31 month

animals parallel those from the 18 month animals.

Experimental

muscle mass for the 31 month animals was 60%, 63%, and 67% of the
control values at 2, 3, and 4 weeks following the bupivacaine
injection.
Results of the force measurements (Fig. 2) are similar to
those for muscle mass.

In the 3 month animals, the force produced

by the bupivacaine injected leg was 58% of the control at 2 weeks,
95 % of the control at 3 weeks, and 105% of the control at four

weeks post-injection.

Force measurements for the adult animals

were 34% of the control at 2 weeks, 30% of control at 3 weeks, and
46% of control at 4 weeks post injection.

In the aged animals,

the force produced by the bupivacaine injected TA was 37% of the
control muscle.

This did not 1ncrease significantly at 3 or 4
12

weeks.
Statistical analysis of this data by the Student - Newman Keuls test and

the Turkey - Kramer test indicated significant

differences between young and adult animals and young and old
animals for both muscle mass and force.

The difference between

the adult and old animals, however, was not significant.

In

addition, a strong correlation existed between the recovery of
muscle mass and force production.

Myogenin mRNA: The presence of myogenin is a powerful indicator of
muscle damage.

In all three age groups and at all three time

periods, myogenin mRNA express1on in the bupivacaine injected legs
was greater than 100 % of control values (Fig. 3).

Myogenin mRNA

decreased slightly between 14, 21, and 28 days 1n the young rats.
It remained elevated at all three time periods 1n the adult rats.
It increased significantly from 14 -28 days in the old rats.

In

addition, the control leg of the old rats had significantly higher
myogenin mRNA levels at all three time periods than the control
legs of the young or adult rats (Fig.4).
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Discussion:

This experiment supports the general proposal that skeletal
muscle regeneration is inhibited with age.

The hypothesis that

the recovery of muscle mass and force generating capacity
following injury occurs later with age is supported by the present
set of experiments.

As seen in figures 1 and Z, the young rats

recover from injury significantly sooner than the adult and old
rats.

The lack of

a

significant difference between the adult and

old rats, however, is surprising.

A qualitative experiment done

by Menachem Sadeh (1988) found that both degeneration and
regeneration were most active in young animals, decrease slightly
in middle age, and are markedly impaired in senescence.
results are expected here, but are not observed.

Similar

One explanation

for this observation could be the age of the adult rats.

In most

cases, an adult rat is considered to to be 9-12 months of age.
However, due to the long life span of the Brown Norway-Fischer 344
cross, 18 months 1s considered middle age.
rat has

a

Although this breed of

longer life span than others, it is possible that the

aging process begins at the same time.

If this is the case, then

an 18 month rat is considered old and regeneration is already
inhibited.
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The results of the myogen1n mRNA analysis are very
interesting.

The mRNA levels in the control leg are slightly

higher than normal.

This is because experimental legs were

useless due to the bupivacaine injection, caus1ng the control legs
to relied upon more heavily than normal.

This extra use caused

slight damaged to fibers, resulting in satellite cell activation.
As expected, myogenin mRNA levels in the experimental legs are
significantly higher than in the control legs for all age groups
and at each time period.

This indicates a higher than normal

degree of satellite cell activation, which directly correlates to
increased regeneration.
Myogenin mRNA levels 1n both the control and bupivacaine
legs of the old animals are significantly higher than those found
in the young or adult animals.

It is known that myogenin is down

regulated by electrical activity ( Eftimie et. al. 1991). High
levels indicate a lack of electrical activity.

This could be due

to poor reinnervation of newly formed myotubes 1n the old rats.
Without proper innervation, muscle fibers die and the regenerative
capacity of old rats is decreased.

A loss of alpha motor neurons

and motor units has been well documented (Ansved and Larson,
1990). The exact cause of this loss, however, is unknown.
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This result indicates that it is not the regenerative
capacity of muscle cells, but changes in the environment which
inhibits regeneration with age.

This result is supported by a

prev1ous study which found that old animals show a decreased
regenerative capacity following free whole muscle transplantation
(Foster, 1980).

Under these circumstances, the whole muscle

degenerates as a result of the ischemic injury.

It was found that

muscles from young or old rats transplanted into young animals
regenerated equally well, but muscles from young or old rats
transplanted into old rats regenerated equally poorly (Carlson and
Faulkner, 1989).

It is not the regenerative capacity of the cell,

but the environment in which the regeneration occurs that impairs
this process in aging animals .
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Figure 1 .

Relative percent changes in the mass of bupivacaine-

injected TA's of young (3 months), middle age (18 months), and old
rats (31 months) compared to the contralateral control at 2, 3,
and 4 weeks after the injection .

23

Muscle Mass

15

-D-- Young

•

Middle Age

---fr- Senescent
T

10
0

~
~

C

1

0

u

~!

'+-

0

~

I

5

.l.

1

2

3
Recovery (weeks)

24

I
1
I

1
4

5

Figure 2. Relative percent changes in force production by the

bupivacaine-injected TA compared to the contralateral control 2,
3, and 4 weeks after injection in young (3 months), middle age (18
months), and old (31 months) rats .
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Figure 3. Relative percent changes in myogen1n mRNA content in

the bupivacaine-injected TA compared to the contralateral control
2, 3, and 4 weeks after injection in young
(18 months), and old (31 months) rats.
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Figure 4. Myogenin mRNA levels in the control and bupivacaine

injected legs of young (3 months), middle age (18 months), and old
(31 months) rats 2, 3, and 4 weeks post-injection.
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